Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans-Reference-Cited by-同舟云学术

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

Published:2009-04 Issue:7 Volume:75 Page:736-745
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Freedman Barry I.,Hicks Pamela J.,Bostrom Meredith A.,Cunningham Mary E.,Liu Yongmei,Divers Jasmin,Kopp Jeffrey B.,Winkler Cheryl A.,Nelson George W.,Langefeld Carl D.,Bowden Donald W.

Publisher

Elsevier BV

Subject

Nephrology

Reference31 articles.

1. USRDS 2006 Annual Data Report. Atlas of end-stage renal disease in the United States;US Renal Data System,2006

2. Clinical documentation of end-stage renal disease due to hypertension;Schlessinger;Am J Kidney Dis,1994

3. The familial risk of end-stage renal disease in African Americans;Freedman;Am J Kidney Dis,1993

4. The link between hypertension and nephrosclerosis;Freedman;Am J Kidney Dis,1995

5. Blood pressure and end-stage renal disease in men;Klag;N Engl J Med,1996

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin supplementation prevents kidney damage and improves long‐term prognosis in hypertensive patients;Phytotherapy Research;2024-09-07

2. Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023;Renal Failure;2024-02-12

3. Precision medicine implementation challenges for APOL1 testing in chronic kidney disease in admixed populations;Frontiers in Genetics;2022-12-15

4. Biochemical and molecular genetic markers of kidney damage in hypertension;"Arterial’naya Gipertenziya" ("Arterial Hypertension");2022-08-01

5. Galectin 3 (LGALS3) Gene Polymorphisms Are Associated with Biochemical Parameters and Primary Disease in Patients with End-Stage Renal Disease in Serbian Population;Journal of Clinical Medicine;2022-07-04